In a report released today, Alex Thompson CFA from Stifel Nicolaus maintained a Buy rating on Oruka Therapeutics (ORKA – Research Report), with ...
Stifel Nicolaus analyst Alex Thompson CFA maintained a Buy rating on Viridian Therapeutics (VRDN – Research Report) today and set a price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback